ebbu is on a mission to place cannabis on the mass adoption stage by creating custom, consistent and predictable product experiences using precise, human-tested formulations.
Cannabis produces hundreds of chemical compounds including cannabinoids and terpenes, many of which are pharmacologically active. In an effort to better understand the impact on the human endocannabinoid system, the ebbu team literally breaks down the many varying and inconsistent strains of cannabis to their root cannabinoid and terpene components, conducts cellular and human studies, and creates unique formulations that are more consistent and scientifically reproducible than plant matter alone could ever be.
ebbu scientists have created five proprietary recreational formulations of cannabinoids and terpenes that replicate different “highs” or sensations. Each formulation can be custom-tweaked to find that perfect sensation for your product.
ebbu’s team of scientists is looking to the future of effect-specific cannabinoid-terpene blends and aggressively working on formulations for therapeutic uses. ebbu is already finishing formulations for:
Anxiety | Depression | Pain | PTSD | Sexy Time | Sleep
Licensing Genetic Technology
ebbu is forming strategic partnerships with cultivators by:
● Licensing ebbu’s patent-pending genetics
● Inoculating crops to genetically alter plant DNA for precise cannabinoid expression
● Developing tissue culture facilities
● Producing mother plants for cultivation facilities